DONALD R. REMPINSKI
** ******** *******, ***********, ** 14225 . 716-***-**** .
************@*****.***
Research Technician with 10+ years experience in culturing mammalian,
insect, and human cancer cell lines. 10+ years experience in bacterial
cloning, requiring PCR and recombinant cell transfection. 6 years
experience in the production of pure and recombinant virus. Willing to
relocate; assistance welcome but not necessary.
Education
B.S. in Biotechnology & B.S in Applied Biology, Ferris State University,
Big Rapids, MI.
Work Experience
Research Technician (Temp: 2/2012-5/2012)
Hauptman-Woodward Research Institute, Buffalo, NY
Worked in a nonprofit biomedical research facility on research projects.
. Maintained mammalian and insect cell lines.
. Experience in protein crystallization analysis, cloning, and western
blot analysis.
Research Technician, Dept. of Cancer Biology (2009-2011)
Roswell Park Cancer Institute, Buffalo, NY
Performed assigned phases of scientific research projects in lab; organized
and analyzed laboratory research efforts; utilized quantitative and
qualitative techniques to analyze human cancer cell lines.
. Experience in cloning and the creation of recombinant cancer cell
lines, biopotency and pharmacokinetic colorimetric cellular assays,
western blot analysis, and flow cytometry.
Research Technologist (2005-2009)
Radioprotectans Group, Cleveland Biolabs, Inc., Cleveland, OH
Created recombinant Lentiviral constructs, and recombinant cell lines with
them.
. Extensive experience with ELISA assays, and with biopotency and
pharmacokinetic cellular assays.
Laboratory Technician (2000-2005)
Virus Core Facility, Cleveland Clinic Foundation, Inc., Cleveland, OH
Extensive experience in creating and producing recombinant Lentiviral and
Retroviral constructs, cloning, and creation of recombinant cell lines.
. Created, produced, and purified recombinant adenovirus and baculovirus
under BSL 2+ conditions.
. Produced and purified HPIV-3, RSV, and VSV.
PUBLICATIONS
Nithya Krishnan, Andrew Fritz, Donald Rempinski, Kieran O' Loughlin, Hans
Minderman, Ronald Berezney, William Marzluff, and Roopa Thapar. The Prolyl
Isomerase Pin1 Targets SLBP To Dissociate The SLBP-Histone mRNA Complex
Linking Histone mRNA Decay With SLBP Ubiquitination. Mol. Cell. Biol. Nov
2012 32: 4306-4322.
M S Saifo, D Rempinski, Y M Rustum, R G Azrak, 2010. Targeting the
Oncogenic Protein Beta-Catenin to Enhance Chemotherapy Outcome against
Solid Human Tumors. Molecular Cancer 9:310.
Frederic J. Reu, Douglas W. Leaman, Ratan R. Maitra, Soo In Bae, Leonid
Cherkassky, Mark W. Fox, Donald R. Rempinski, Normand Beaulieu, A. Robert
MacLeod, and Ernest C. Borden. Expression of RASSF1A, an epigenetically
silenced tumor suppressor, overcomes resistance to apoptosis induction by
interferons. Cancer Research 66, 2785-2793, March 1, 2006.
TECHNICAL COMPETENCIES
Bacterial Cloning Producing recombinant DNA for later expression-
requires PCR, ligations, preparing DNA stocks, and
enzymatic analysis.
Biopotency assays Determination of the stability and potency of target
drugs using standard and nonstandard colorimetric
methods.
DNA stock preparation Transformation and large-scale preparation of
plasmid DNA.
ELISA assays Determination of drug antibody titer in mouse, primate,
and human serum.
Flow Cytometry Used to determine the effects of said drugs on
cell populations.
Maintenance of Cell Lines Maintenance of live and frozen stocks of each
line used.
Pharmacokinetic assays Used to determine the effects or the degradation
rate of target drugs in media over time.
Preparation of Recombinant Cloning of different genes into Lentiviral
vectors for expression in
Lentivirus mammalian cells.
Protein Crystallization Used to locate crystallized proteins under
particular growth conditions.
Prokaryotic Expression Transforming a recombinant gene into PET-49(b+)
vector for its expression and production.
Recombinant Cell Line Creating recombinant (knockout) cell lines
using cloned DNA.
Creation
Western Blot Analysis Used to determine cell protein levels after
drug treatment.
Preparation of Recombinant Adenovirus/Baculovirus
Making recombinant adeno/baculovirus by cotransfecting the gene of interest
(within a shuttle vector) and an adenoviral or baculoviral vector into
mammalian cells.
Production & Purification of Recombinant and Purified Virus
Preparation of large quantities (>10mg) of virus allowed end users to
proceed with experiments without taking the time to do so themselves, at a
lower cost and in less time than outsourcing.
Production & Purification of Hazardous Pathogens
HPIV3, VSV, RSV-Preparations accomplished under BSL-2+ conditions.